4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-16-000095
CEO bought 20,000 shares at an average $0.13 ($2,515)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-10-07 | Purchase : show line 1 in the form | +10,000 | $0.13 | $1,290 | 7,225,579 | D |
| 2016-10-07 | Purchase : show line 2 in the form | +5,000 | $0.13 | $625 | 7,230,579 | D |
| 2016-10-07 | Purchase : show line 3 in the form | +5,000 | $0.12 | $600 | 7,235,579 | D |
| Open-market purchases · 20,000 sh · avg $0.13 · $2,515 | ||||||
Loading xslF345X03/primary_doc.xml…